Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient dataPaul A. Cohen, Arjun Jeyarajah, Max Bulsara et al.|Gynecologic Oncology|2019Cited by 121
The Tumor Microenvironment of Clear-Cell Ovarian CancerMichael-John Devlin, Frances R. Balkwill, Rowan Miller et al.|Cancer Immunology Research|2022Cited by 41
Pembrolizumab in Patients With Advanced Clear Cell Gynecological CancerRebecca Kristeleit, Rowan Miller, Michael-John Devlin et al.|JAMA Oncology|2025Cited by 32